703 related articles for article (PubMed ID: 30466095)
21. LncRNA HOXA-AS2 accelerates the proliferation and migration and inhibits the apoptosis of vascular smooth muscle cells by absorbing miRNA-877-3p.
Fan TT; Liu YX; Wang XC; Xu BL; Chen ZC; Lu HA; Zhang M
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):362-368. PubMed ID: 31957850
[TBL] [Abstract][Full Text] [Related]
22. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.
Zhang B; Sun YF; Zhang XM; Jiang N; Chen Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4940-4953. PubMed ID: 32432757
[TBL] [Abstract][Full Text] [Related]
23. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
[TBL] [Abstract][Full Text] [Related]
24. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis.
Zhang X; Yang L; Xu G
Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119
[TBL] [Abstract][Full Text] [Related]
25. HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.
Sun J; Wang L
BMC Cancer; 2022 Apr; 22(1):366. PubMed ID: 35387643
[TBL] [Abstract][Full Text] [Related]
26. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
Li HJ; Sun XM; Li ZK; Yin QW; Pang H; Pan JJ; Li X; Chen W
Cell Physiol Biochem; 2017; 43(6):2548-2561. PubMed ID: 29130995
[TBL] [Abstract][Full Text] [Related]
27. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.
Yu Y; Kou D; Liu B; Huang Y; Li S; Qi Y; Guo Y; Huang T; Qi X; Jia L
Int J Lab Hematol; 2020 Aug; 42(4):464-472. PubMed ID: 32359033
[TBL] [Abstract][Full Text] [Related]
28. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
Li J; Wang M; Chen X
Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
31. LncRNA SNHG5 regulates SOX4 expression through competitive binding to miR-489-3p in acute myeloid leukemia.
Ying X; Zhang W; Fang M; Wang C; Han L; Yang C
Inflamm Res; 2020 Jun; 69(6):607-618. PubMed ID: 32266420
[TBL] [Abstract][Full Text] [Related]
32. LncRNA HOXA-AS2 Promotes Temozolomide Resistance in Glioblastoma by Regulated miR-302a-3p/IGF1 Axis.
Lin L; Lin D; Jin L; Wang J; Lin Z; Zhang S; Lin G
Genet Res (Camb); 2022; 2022():3941952. PubMed ID: 36479381
[TBL] [Abstract][Full Text] [Related]
33. LncRNA DLEU2 promotes tumour growth by sponging miR-337-3p in human osteosarcoma.
Liu W; Liu PC; Ma K; Wang YY; Chi QB; Yan M
Cell Biochem Funct; 2020 Oct; 38(7):886-894. PubMed ID: 32196715
[TBL] [Abstract][Full Text] [Related]
34. Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia.
Liu B; Ma X; Liu Q; Xiao Y; Pan S; Jia L
Cell Death Dis; 2018 Jun; 9(6):688. PubMed ID: 29880818
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis.
Chen R; He P
J Pharm Pharmacol; 2021 Sep; 73(10):1387-1396. PubMed ID: 34240204
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia.
Wang D; Zeng T; Lin Z; Yan L; Wang F; Tang L; Wang L; Tang D; Chen P; Yang M
Biomed Pharmacother; 2020 Mar; 123():109802. PubMed ID: 31884339
[TBL] [Abstract][Full Text] [Related]
37. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a.
Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP
Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533
[TBL] [Abstract][Full Text] [Related]
38. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of HOXA-AS2 inhibits inflammation and apoptosis in podocytes via sponging miRNA-302b-3p to upregulate TIMP3.
Li X; Yu HM
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4963-4970. PubMed ID: 32432759
[TBL] [Abstract][Full Text] [Related]
40. High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.
Liu Y; Gao X; Tian X
Eur J Pharmacol; 2019 Sep; 859():172535. PubMed ID: 31306637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
